Literature DB >> 32202953

Anticardiolipin from Periodontitis Patients Impact Fetal Loss and Annexin V.

H A Schenkein1, R R Thomas1.   

Abstract

Anticardiolipin antibodies, found at elevated serum concentrations in 15% to 20% of individuals with periodontitis, are associated with adverse pregnancy outcomes, thrombotic conditions, and accelerated atherosclerosis in autoimmune disease such as the antiphospholipid syndrome. Our previous studies demonstrated that antibodies raised in mice against Porphyromonas gingivalis caused fetal loss in a mouse pregnancy model due to anticardiolipin antibodies. Such antibodies are induced via molecular mimicry with the serum protein β2-glycoprotein 1 (β2GP1), the target antigen of anticardiolipin. Furthermore, human anticardiolipin IgG is associated with increased serum markers of vascular inflammation, and IgG purified from periodontitis subjects with elevated anticardiolipin stimulates inflammatory cytokine production by endothelial cells and a trophoblastic cell line. Activation of the trophoblastic cells by anticardiolipin occurs through Toll-like receptor 4. In the present study, we observed that IgG anticardiolipin from periodontitis subjects also causes fetal loss in mice. Displacement of the protective 2-dimensional lattice formed by annexin V on trophoblast surfaces by anticardiolipin, via its interaction with its target antigen β2GP1, leading to fibrin clot formation due to exposure of anionic phospholipids to plasma, is a plausible pathogenic mechanism explaining adverse obstetrical outcomes in antiphospholipid syndrome. Therefore, we assessed such interactions in periodontitis. We observed that anticardiolipin from periodontitis subjects competes for annexin V on an artificial phosphatidylserine monolayer, replicating a key activity of autoantibodies found in patients with antiphospholipid syndrome. In addition, we found that anticardiolipin from periodontitis subjects increases annexin V levels on the BeWo choriocarcinoma cell line, consistent with mobilization of annexin V to the cell surface to facilitate repair following membrane damage. The data indicate that sera and IgG from periodontitis subjects with elevated anticardiolipin levels may influence pregnancy outcomes due to interactions with annexin V.

Entities:  

Keywords:  antibodies; autoimmunity; immunity; molecular mimicry; periodontal disease(s); pregnancy outcome

Mesh:

Substances:

Year:  2020        PMID: 32202953      PMCID: PMC7313349          DOI: 10.1177/0022034520913244

Source DB:  PubMed          Journal:  J Dent Res        ISSN: 0022-0345            Impact factor:   6.116


  41 in total

1.  Progressive periodontal disease and risk of very preterm delivery.

Authors:  Steven Offenbacher; Kim A Boggess; Amy P Murtha; Heather L Jared; Susan Lieff; Rosemary G McKaig; Sally M Mauriello; Kevin L Moss; James D Beck
Journal:  Obstet Gynecol       Date:  2006-01       Impact factor: 7.661

2.  Association between periodontitis and anti-cardiolipin antibodies in Buerger disease.

Authors:  Yi-Wen Chen; Toshiyuki Nagasawa; Nawarat Wara-Aswapati; Yuka Ushida; Dongqing Wang; Yasuo Takeuchi; Hiroaki Kobayashi; Makoto Umeda; Yoshinori Inoue; Takehisa Iwai; Isao Ishikawa; Yuichi Izumi
Journal:  J Clin Periodontol       Date:  2009-08-12       Impact factor: 8.728

3.  Competition of annexin V and anticardiolipin antibodies for binding to phosphatidylserine containing membranes.

Authors:  G M Willems; M P Janssen; P Comfurius; M Galli; R F Zwaal; E M Bevers
Journal:  Biochemistry       Date:  2000-02-29       Impact factor: 3.162

Review 4.  β2-glycoprotein I and its antibodies involve in the pathogenesis of the antiphospholipid syndrome.

Authors:  Aiping Bai
Journal:  Immunol Lett       Date:  2017-03-24       Impact factor: 3.685

5.  Correlation between antiphospholipid antibodies that recognize domain I of beta2-glycoprotein I and a reduction in the anticoagulant activity of annexin A5.

Authors:  Bas de Laat; Xiao-Xuan Wu; Menno van Lummel; Ronald H W M Derksen; Philip G de Groot; Jacob H Rand
Journal:  Blood       Date:  2006-10-19       Impact factor: 22.113

6.  A new classification scheme for periodontal and peri-implant diseases and conditions - Introduction and key changes from the 1999 classification.

Authors:  Jack G Caton; Gary Armitage; Tord Berglundh; Iain L C Chapple; Søren Jepsen; Kenneth S Kornman; Brian L Mealey; Panos N Papapanou; Mariano Sanz; Maurizio S Tonetti
Journal:  J Periodontol       Date:  2018-06       Impact factor: 6.993

7.  Anti-cardiolipin from periodontitis patients induces MCP-1 production by human umbilical vein endothelial cells.

Authors:  Harvey A Schenkein; Robert Sabatini; Thomas E Koertge; Carol N Brooks; Donald B Purkall
Journal:  J Clin Periodontol       Date:  2013-01-02       Impact factor: 8.728

Review 8.  Extracellular annexin A5: functions of phosphatidylserine-binding and two-dimensional crystallization.

Authors:  Hugo O van Genderen; Heidi Kenis; Leo Hofstra; Jagat Narula; Chris P M Reutelingsperger
Journal:  Biochim Biophys Acta       Date:  2008-02-20

9.  Serum anticardiolipin concentrations in patients with chronic periodontitis following scaling and root planing.

Authors:  Reve Chaston; Robert Sabatini; Thomas E Koertge; Carol N Brooks; Harvey A Schenkein
Journal:  J Periodontol       Date:  2013-10-21       Impact factor: 6.993

Review 10.  Obstetric antiphospholipid syndrome: a recent classification for an old defined disorder.

Authors:  Silvia D'Ippolito; Pier Luigi Meroni; Takao Koike; Manuela Veglia; Giovanni Scambia; Nicoletta Di Simone
Journal:  Autoimmun Rev       Date:  2014-05-10       Impact factor: 9.754

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.